Paul Nouri, CFP
Hedge fund manager, long/short equity, healthcare

Could Medtronic Have Better Spent $43 Billion?

Medtronic (NYSE:MDT), the largest independent med-tech company in the U.S., announced a deal to acquire Covidien (COV), a significant med-tech peer, for $93.22 per share, representing a 29% premium from the closing price on June 13. Given the significant premium and fair valuation, I don't expect significant shareholders to a...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
WITH SEEKING ALPHA PRO, INVESTORS CAN ALSO:
  • Access Top Ideas, chosen by Seeking Alpha’s editors
  • Filter long and short ideas by market cap and sector
  • Get Coverage of over 5,000 stocks, many of which have little or no coverage elsewhere
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO." Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else." Patrick Rice, Mainstay Capital Management
100% Satisfaction Guaranteed
You are protected by the Seeking Alpha Money Back Guarantee and will get a prompt refund on the unused portion of your subscription at any time, for any reason.